Patents by Inventor Charles Friedman
Charles Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210337902Abstract: A method of making a face shield using a bar tack stitch to join a face shield lens to a backing. The backing may be a headband or the combination of the headband and a cushion. The lens and the optional cushion may be joined together and then the lens may be stitched to the cushion and the headband. A bar tack stitch may be used to join the backing and lens together. Stitching the lens to its backing produces a novel face shield with high quality structural integrity that can be made quickly and cost effectively to eliminate limitations associated with bonded face shield lenses and removable joined face shield lenses.Type: ApplicationFiled: April 30, 2020Publication date: November 4, 2021Applicant: Lifethereal LLCInventor: Charles Friedman
-
Patent number: 11122798Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.Type: GrantFiled: March 16, 2020Date of Patent: September 21, 2021Assignee: Monsanto Technology LLCInventors: Wenjin Deng, Todd Charles Friedman, John W. Hemminghaus, Liwei Yuan, Junhua Zhang
-
Publication number: 20200281196Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.Type: ApplicationFiled: March 16, 2020Publication date: September 10, 2020Applicant: Monsanto Technology LLCInventors: Wenjin Deng, Todd Charles Friedman, John W. Hemminghaus, Liwei Yuan, Junhua Zhang
-
Patent number: 10638751Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.Type: GrantFiled: January 6, 2016Date of Patent: May 5, 2020Assignee: Monsanto Technology LLCInventors: Junhua Zhang, John W. Hemminghaus, Todd Charles Friedman, Wenjin Deng, Liwei Yuan
-
Publication number: 20160192645Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.Type: ApplicationFiled: January 6, 2016Publication date: July 7, 2016Applicant: Monsanto Technology LLCInventors: Junhua Zhang, John W. Hemminghaus, Todd Charles Friedman, Wenjin Deng, Liwei Yuan
-
Publication number: 20160136148Abstract: The invention relates to solid dispersions containing paroxetine mesylate. One solid dispersion contains amorphous paroxetine mesylate and a methacrylic acid-methyl methacrylate copolymer, where the weight ratio of paroxetine mesylate to polymer ranges from about 30:70 to about 90:10. Another solid dispersion contains amorphous paroxetine mesylate and a-vinylpyrrolidone/vinylacetate copolymer (PVP-VA), where the weight ratio of paroxetine mesylate to copolymer ranges from about 30:70 to about 50:50. An amorphous solid dispersion of the invention may have a single glass transition temperature. An amorphous solid dispersion is stable for at least 48 hours at 60° C. and 75% relative humidity. A further embodiment of the invention relates to pharmaceutical compositions of paroxetine mesylate comprising a solid dispersion of the invention and at least one pharmaceutically acceptable excipient.Type: ApplicationFiled: November 10, 2015Publication date: May 19, 2016Applicant: NOVEN THERAPEUTICS, LLCInventors: David A. Engers, Yonglai Yang, Stephen Parent, Travis Houston, Bruce Charles Friedman
-
Patent number: 9211290Abstract: The invention relates to solid dispersions containing paroxetine mesylate. One solid dispersion contains amorphous paroxetine mesylate and a methacrylic acid-methyl methacrylate copolymer, where the weight ratio of paroxetine mesylate to polymer ranges from about 30:70 to about 90:10. Another solid dispersion contains amorphous paroxetine mesylate and a -vinylpyrrolidone/vinylacetate copolymer (PVP-VA), where the weight ratio of paroxetine mesylate to copolymer ranges from about 30:70 to about 50:50. An amorphous solid dispersion of the invention may have a single glass transition temperature. An amorphous solid dispersion is stable for at least 48 hours at 60° C. and 75% relative humidity. A further embodiment of the invention relates to pharmaceutical compositions of paroxetine mesylate comprising a solid dispersion of the invention and at least one pharmaceutically acceptable excipient.Type: GrantFiled: March 15, 2013Date of Patent: December 15, 2015Assignee: NOVEN THERAPEUTICS, LLCInventors: David A. Engers, Yonglai Yang, Stephan Parent, Travis Houston, Bruce Charles Friedman
-
Publication number: 20140187582Abstract: The invention relates to solid dispersions containing paroxetine mesylate. One solid dispersion contains amorphous paroxetine mesylate and a methacrylic acid-methyl methacrylate copolymer, where the weight ratio of paroxetine mesylate to polymer ranges from about 30:70 to about 90:10. Another solid dispersion contains amorphous paroxetine mesylate and a -vinylpyrrolidone/vinylacetate copolymer (PVP-VA), where the weight ratio of paroxetine mesylate to copolymer ranges from about 30:70 to about 50:50. An amorphous solid dispersion of the invention may have a single glass transition temperature. An amorphous solid dispersion is stable for at least 48 hours at 60° C. and 75% relative humidity. A further embodiment of the invention relates to pharmaceutical compositions of paroxetine mesylate comprising a solid dispersion of the invention and at least one pharmaceutically acceptable excipient.Type: ApplicationFiled: March 15, 2013Publication date: July 3, 2014Inventors: David A. ENGERS, Yonglai YANG, Stephan PARENT, Travis HOUSTON, Bruce Charles FRIEDMAN
-
Publication number: 20110125230Abstract: A light therapy device includes a first module adapted to be coupled to a head of an individual, and a second module including at least one light, the second module being coupled to the first module so that the second module is positioned relative to the individual's eyes, and the second module powering the light to provide indirect light therapy to the individual.Type: ApplicationFiled: November 23, 2009Publication date: May 26, 2011Inventors: Ronald Charles Friedman, Kingman P. Strohl, Phyllis C. Zee
-
Publication number: 20060025108Abstract: Mobile communications devices display contextually relevant information based on the presence, status, and identification of a user. Lens templates control how the information is displayed and can be customized and designed for specific usage profiles. The lenses that are used can be updated at any time to accommodate changes in a user's presence. The granularity of the lenses and corresponding information can also vary to accommodate different needs and preferences. Lenses can also be specialized for different events or venues. The lenses allow a user to access contextually relevant information from a mobile communications device having limited display and/or browse capabilities without requiring a user to navigate through undesired information, wasting valuable resources in the process.Type: ApplicationFiled: September 15, 2005Publication date: February 2, 2006Applicant: Microsoft CorporationInventors: Mike Pell, Charles Friedman
-
Publication number: 20060019716Abstract: Mobile communications devices display contextually relevant information based on the presence, status, and identification of a user. Lens templates control how the information is displayed and can be customized and designed for specific usage profiles. The lenses that are used can be updated at any time to accommodate changes in a user's presence. The granularity of the lenses and corresponding information can also vary to accommodate different needs and preferences. Lenses can also be specialized for different events or venues. The lenses allow a user to access contextually relevant information from a mobile communications device having limited display and/or browse capabilities without requiring a user to navigate through undesired information, wasting valuable resources in the process.Type: ApplicationFiled: September 15, 2005Publication date: January 26, 2006Applicant: Microsoft CorporationInventors: Mike Pell, Charles Friedman